Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/23983
Title: Marek’s Disease Virus Modulates T Cell Proliferation via Activation of Cyclooxygenase 2-Dependent Prostaglandin E2
Authors: Kamble, N
Gurung, A
Kaufer, BB
Pathan, AA
Behboudi, S
Keywords: Marek’s disease virus;T cell proliferation;cyclooxygenase 2 (COX2);PGE2;immunosuppression
Issue Date: 22-Dec-2021
Publisher: Frontiers Media S.A.
Citation: Kamble, N., Gurung, A., Kaufer, B.B., Pathan, A.A. and Behboudi, S. (2021) 'Marek’s Disease Virus Modulates T Cell Proliferation via Activation of Cyclooxygenase 2-Dependent Prostaglandin E2', Frontiers in Immunology, 12, 801781, pp. 1-16. doi: 10.3389/fimmu.2021.801781.
Abstract: Copyright © 2021 Kamble, Gurung, Kaufer, Pathan and Behboudi. Marek’s disease virus (MDV), an avian alphaherpesvirus, infects chickens, transforms CD4+ T cells, and induces immunosuppression early during infection. However, the exact mechanisms involved in MDV-induced immunosuppression are yet to be identified. Here, our results demonstrate that MDV infection in vitro and in vivo induces activation of cyclooxygenase-2 (COX-2) and production of prostaglandin E2 (PGE2). This exerts its inhibitory effects on T cell proliferation at day 21 post infection via PGE2 receptor 2 (EP2) and receptor 4 (EP4). Impairment of the MDV-induced T cell proliferation was associated with downregulation of IL-2 and transferrin uptake in a COX-2/PGE2 dependent manner in vitro. Interestingly, oral administration of a COX-2 inhibitor, meloxicam, during MDV infection inhibited COX-2 activation and rescued T cell proliferation at day 21 post infection. Taken together, our results reveal a novel mechanism that contributes to immunosuppression in the MDV-infected chickens.
URI: https://bura.brunel.ac.uk/handle/2438/23983
DOI: https://doi.org/10.3389/fimmu.2021.801781
Other Identifiers: 801781
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdf9.04 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons